Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.

Clinical research sponsor

Published trials26
Recruiting shown5
Roles2
SourceClinicalTrials.gov

Clinical trials

26 shown
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive DisorderNCT06958692 · lead sponsor · 2025-04-11
RECRUITING
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or MetforminNCT07796477 · lead sponsor · 2026-11-06
NOT_YET_RECRUITING
Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.NCT07803991 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
A Study of SYH2082 Injection in Healthy ParticipantsNCT07736404 · lead sponsor · 2026-04-13
ACTIVE_NOT_RECRUITING
A Study of SYH2069 Injection in Healthy ParticipantsNCT07736391 · lead sponsor · 2026-01-10
ACTIVE_NOT_RECRUITING
A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesNCT07026968 · lead sponsor · 2025-06-20
ACTIVE_NOT_RECRUITING
A Study to Evaluate Pregabalin in Painful Diabetic Peripheral NeuropathyNCT06383702 · lead sponsor · 2024-05-15
UNKNOWN
A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011NCT06354114 · lead sponsor · 2024-04-01
NOT_YET_RECRUITING
A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)NCT05753865 · lead sponsor · 2023-05-01
UNKNOWN
A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast CancerNCT05274893 · lead sponsor · 2022-03-31
UNKNOWN
Study of Irinotecan Liposome Injection in Patients With Advanced Breast CanceNCT04728035 · lead sponsor · 2021-05-31
COMPLETED
Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)NCT04727853 · lead sponsor · 2021-03-01
COMPLETED
Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral NeuropathyNCT05341141 · collaborator · 2022-06-10
RECRUITING
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast CancerNCT05159193 · collaborator · 2021-12-20
RECRUITING
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast CancerNCT04138719 · collaborator · 2019-11-20
RECRUITING
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast CancerNCT04159142 · collaborator · 2019-11-20
RECRUITING
Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast CancerNCT06156761 · collaborator · 2023-11-28
UNKNOWN
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast CancerNCT05843292 · collaborator · 2023-07-01
NOT_YET_RECRUITING
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world StudyNCT05287308 · collaborator · 2022-03-01
NOT_YET_RECRUITING
To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical StudyNCT05656079 · collaborator · 2021-07-01
UNKNOWN
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerNCT03994107 · collaborator · 2019-10-01
UNKNOWN
Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.NCT03983096 · collaborator · 2019-07-07
COMPLETED
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerNCT03802058 · collaborator · 2019-03-20
TERMINATED
Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast CancerNCT03933319 · collaborator · 2019-03-11
UNKNOWN
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy SubjectsNCT03657550 · collaborator · 2018-05-31
COMPLETED
Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness ResearchNCT01844570 · collaborator · 2013-02-01
UNKNOWN

Sponsor roles

collaborator14
lead sponsor12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.